ON-DEMAND WEBINARS

Explore the advancing mass spectrometry, biophysical characterization, automated sample preparation, and high throughput analytics required to deliver medicines in a safe, compliant, and efficient manner.

This comprehensive exploration aims to shed light on the critical aspects of expediting curative therapies, with a focus on the strategic role that CDMOs can play in this transformative journey.

Launching a large molecule in one format and then switching the delivery format often transpires as a lifecycle management strategy for cost efficiency, supply chain continuity, and patient benefit. 

Led by Dr. Richard Johnson, Chief Scientific Officer, this 40-minute session covers the five key stages of the UpperNose development platform, highlighting the significance of target product selection and its influence on formulation and clinical outcomes.

ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

Tom von Gunden, Chief Editor & Community Director, Drug Delivery Leader

Tom hosts multiple videocast series providing expert takes and insider perspectives on drug delivery:

Talk to Tom today!


Fran DeGrazio, Executive Editor - Drug Delivery Leader & Frankly Fran

In her monthly column, Fran offers keen industry insights exclusively on Drug Delivery Leader.

FRANKLY FRAN

  • In this article, Fran DeGrazio recounts the evolution of drug delivery technologies as she underscores the need to innovate in the delivery of advanced therapies. Considering chronic diseases, rare diseases, and difficult-to-reach therapeutic targets, Fran offers suggestions for organizing and readying for the development and delivery of platforms, systems, and devices for next generation treatments, including personalized, precision medicines.

FREE EBOOK: COMBINATION PRODUCTS

Combination products provide significant avenues for increasing patient adherence and overall efficacy. This collection outlines the opportunity and identifies strategies for gaining regulatory approval.